Biospecifics Technologies Corp (NASDAQ:BSTC)
| 15.79 Data as of 4:00pm ET |  +0.13 / +0.83%Today’s Change | 12.52 Today|||52-Week Range 21.99 | +5.62% Year-to-Date |
Latest BSTC News | Press Releases
| Company News for May 13, 2013 - Corporate Summary May 13 / Zacks.com |
Today’s Trading
| Previous close | 15.66 |
| Today’s open | 15.77 |
| Day’s range | 15.58 - 15.80 |
| Volume | 30,735 |
| Average volume (3 months) | 14,976 |
| Market cap | $99.4M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -54.74% |
| Earnings growth (this year) | -6.20% |
| Earnings growth (next 5 years) | +27.00% |
| Revenue growth (last year) | -2.20% |
| P/E ratio | 30.4 |
| Price/Sales | 8.52 |
| Price/Book | 5.71 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ENZEnzo Biochem Inc | +0.04 | +1.78% |
| CDXSCodexis Inc | +0.03 | +1.48% |
| PBMDPrima BioMed Ltd | 0.00 | 0.00% |
| ONTYOncothyreon Inc | 0.00 | 0.00% |
Data as of 4:00pm ET, 05/21/2013
Financials
| Next reporting date | August 14, 2013 |
| EPS forecast (this quarter) | $0.07 |
| Annual revenue (last year) | $11.1M |
| Annual profit (last year) | $3.0M |
| Net profit margin | 26.75% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President, CEO, CFO, CAO & Secretary Thomas L. Wegman |
Controller James Goris |
Corporate headquarters Lynbrook, New York |
Forecasts
